IPCA Laboratories
BSE: 524494 | NSE: IPCALAB | ISIN: INE571A01038 | SECTOR: Biotechnology & DrugsOpen
1,347.65High
1,349.00Low
1,321.25Prev Close
1,347.45P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
336.41BVolume
8.88KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
524494NSE
IPCALABISIN
INE571A01038
Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.
Company Officers
Premchand Godha
Executive Chairman of the BoardPranay Godha
Chief Executive Officer, Managing Director, Executive DirectorAjit Jain
Chief Financial Officer, Managing Director, Executive DirectorPabitra Bhattacharya
President - Operations (API)Sunil Ghai
President - MarketingSanjay Kapadia
President - Corporate Quality AssuranceAshok Kumar
President - Research and Development (Chemicals)Shailesh Laul
President - Operations (Formulations)Hitesh Maheshwari
President - Research and Development (Formulations)Shashil Mendonsa
President - International Marketing